Home›Stock Screener›Beryl Drugs›P/E Ratio

Beryl Drugs P/E Ratio

Current P/E Ratio
20.85
Moderate Valuation
High - Growth expectations or overvalued

Beryl Drugs P/E ratio. Beryl Drugs (BERLDRG) P/E ratio is 20.85 (Moderate), EPS (TTM) ₹0.84, current price ₹24.84 on BSE — High - Growth expectations or overvalued. Check Beryl Drugs market cap to track the company's total market size over time.

Current Valuation Metrics

P/E Ratio 20.85
Current Price ₹24.84
EPS (TTM) ₹0.84
Exchange BSE

Valuation Signal

Signal Overvalued

Sector Context

Sector Average 56.41
Sector Median 32.41
Sector Rank #11 of 199
Sector Percentile 5.5%

BERLDRG P/E Ratio — Valuation Signal & Historical Context

Beryl Drugs P/E 20.85 — signal: Overvalued. Also explore BERLDRG price movement history to track price trends across different timeframes.

  • Trading at discount to sector average PE of 56.41

BERLDRG vs Healthcare Peers — P/E Ratio Comparison

Beryl Drugs P/E 20.85 vs Healthcare average 56.41, median 32.41 — range 2.04–740.29.

Sector Average
56.41
Sector Median
32.41
Lowest P/E
2.04
Highest P/E
740.29
Companies
199
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Sunrest Lifescience SUNREST 2.04 ₹65 Low
Murae Organisor MURAE 2.86 ₹41 Low
Phaarmasia PHRMASI 3.41 ₹63 Low
Sun Pharma Advanced Rese… SPARC 3.98 ₹6,206 Low
Dipna Pharmachem DPL 4.57 ₹12 Low
JFL Life Sciences JFLLIFE 4.88 ₹66 Low
GKB Ophthalmics GKB 5.88 ₹32 Low
Kabra Drugs KABRADG 6.09 ₹44 Low
Royal Sense ROYAL 6.58 ₹47 Low
Colinz Laboratories COLINZ 6.62 ₹18 Low